CareRx Corporation

DB:29C1 Stock Report

Market Cap: €74.4m

CareRx Future Growth

Future criteria checks 0/6

CareRx is forecast to grow earnings and revenue by 20.9% and 4.5% per annum respectively while EPS is expected to grow by 115.3% per annum.

Key information

20.9%

Earnings growth rate

115.3%

EPS growth rate

Consumer Retailing earnings growth10.5%
Revenue growth rate4.5%
Future return on equityn/a
Analyst coverage

Good

Last updated12 Aug 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:29C1 - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026413N/AN/AN/A2
12/31/2025386-5N/AN/A6
12/31/2024367-524318
6/30/2024367-72734N/A
3/31/2024369-42332N/A
12/31/2023371-51927N/A
9/30/2023374-62533N/A
6/30/2023378-73038N/A
3/31/2023380-341629N/A
12/31/2022382-34922N/A
9/30/2022384-34-411N/A
6/30/2022358-36-510N/A
3/31/2022311-20-18N/A
12/31/2021263-2307N/A
9/30/2021212-2127N/A
6/30/2021187-24-6-3N/A
3/31/2021177-29-20N/A
12/31/2020162-18-20N/A
9/30/2020148-50-3-1N/A
6/30/2020134-47-20N/A
3/31/2020126-34-12N/A
12/31/2019125-4636N/A
9/30/2019122-19-13N/A
6/30/2019119-20-24N/A
3/31/2019117-3959N/A
12/31/2018119-3527N/A
9/30/201885-27814N/A
6/30/201897-23512N/A
3/31/2018110-3N/A15N/A
12/31/2017122-4N/A16N/A
9/30/2017168-6N/A14N/A
6/30/2017170-3N/A24N/A
3/31/2017170-13N/A10N/A
12/31/2016167-18N/A2N/A
9/30/2016166-21N/A6N/A
6/30/2016166-34N/A3N/A
3/31/2016164-30N/A20N/A
12/31/2015161-35N/A29N/A
9/30/201527-47N/A28N/A
6/30/201560-48N/A22N/A
3/31/201597-49N/A18N/A
12/31/2014135-44N/A20N/A
9/30/2014301-48N/A23N/A
6/30/2014295-43N/A26N/A
3/31/2014289-49N/A24N/A
12/31/2013281-39N/A20N/A
9/30/2013319-57N/A26N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 29C1 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 29C1 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 29C1 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 29C1's revenue (4.5% per year) is forecast to grow slower than the German market (5.5% per year).

High Growth Revenue: 29C1's revenue (4.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 29C1's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y